Researchers at LUCID (LUMC) have used advanced techniques to demonstrate how a new antibiotic works. The molecule anchors itself with a hook in an important enzyme, thereby blocking the production of bacterial DNA. This research is a strong example of collaboration between academia and the pharmaceutical industry in the fight against antimicrobial resistance, one of the greatest threats to global health.
Read more&width=710&height=710)
A driving force
LUMC strongly underpins the idea that ‘Science is the driving force behind innovative healthcare’. Outcomes of top level fundamental, translational and clinical research by LUMC researchers form a strong basis for innovative and qualitative healthcare on a national, European and international level.
A real game changer was the development of the Dutch national research agenda (NWA) in 2015. The agenda reveals the complexity of the issues challenging Dutch society today. These issues are clustered in so called routes. LUMC is involved in many of these routes and contributes this way to solving important societal challenges.